pipette
ESEspañol

Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo

S. Merritt, J. Kindrachuk, D. Nkamba, N. A. Hoff, H. Kalengi, M. Halbrook, L. Kamba, M. Beya, S. Petrichko, H. L. Wallace, C. Luhata, D. Kaba, A. W. Rimoin

PreprintReal-world useEasy to read

In the authors' words

We report general acceptance (79.0%) of Ebola vaccination in the Democratic Republic of the Congo (DRC) between 2023-2024 (n=5,062). Acceptance varied significantly by province with acceptance ranging from 47.6% in Kongo Central to 92.1% in Tshuapa province and was highest among healthcare workers. While Ebola vaccine acceptance and disease knowledge are relatively strong nationally in the DRC, regional differences do exist and may impact future vaccine rollout.

Main resultLimitation the authors admit

Appeared: Tuesday, October 20. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.15.26365673